Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr 19:9:414.
doi: 10.3389/fphys.2018.00414. eCollection 2018.

Comparing Reentrant Drivers Predicted by Image-Based Computational Modeling and Mapped by Electrocardiographic Imaging in Persistent Atrial Fibrillation

Affiliations

Comparing Reentrant Drivers Predicted by Image-Based Computational Modeling and Mapped by Electrocardiographic Imaging in Persistent Atrial Fibrillation

Patrick M Boyle et al. Front Physiol. .

Abstract

Electrocardiographic mapping (ECGI) detects reentrant drivers (RDs) that perpetuate arrhythmia in persistent AF (PsAF). Patient-specific computational models derived from late gadolinium-enhanced magnetic resonance imaging (LGE-MRI) identify all latent sites in the fibrotic substrate that could potentially sustain RDs, not just those manifested during mapped AF. The objective of this study was to compare RDs from simulations and ECGI (RDsim/RDECGI) and analyze implications for ablation. We considered 12 PsAF patients who underwent RDECGI ablation. For the same cohort, we simulated AF and identified RDsim sites in patient-specific models with geometry and fibrosis distribution from pre-ablation LGE-MRI. RDsim- and RDECGI-harboring regions were compared, and the extent of agreement between macroscopic locations of RDs identified by simulations and ECGI was assessed. Effects of ablating RDECGI/RDsim were analyzed. RDsim were predicted in 28 atrial regions (median [inter-quartile range (IQR)] = 3.0 [1.0; 3.0] per model). ECGI detected 42 RDECGI-harboring regions (4.0 [2.0; 5.0] per patient). The number of regions with RDsim and RDECGI per individual was not significantly correlated (R = 0.46, P = ns). The overall rate of regional agreement was fair (modified Cohen's κ0 statistic = 0.11), as expected, based on the different mechanistic underpinning of RDsim- and RDECGI. nineteen regions were found to harbor both RDsim and RDECGI, suggesting that a subset of clinically observed RDs was fibrosis-mediated. The most frequent source of differences (23/32 regions) between the two modalities was the presence of RDECGI perpetuated by mechanisms other than the fibrotic substrate. In 6/12 patients, there was at least one region where a latent RD was observed in simulations but was not manifested during clinical mapping. Ablation of fibrosis-mediated RDECGI (i.e., targets in regions that also harbored RDsim) trended toward a higher rate of positive response compared to ablation of other RDECGI targets (57 vs. 41%, P = ns). Our analysis suggests that RDs in human PsAF are at least partially fibrosis-mediated. Substrate-based ablation combining simulations with ECGI could improve outcomes.

Keywords: ablation; atrial fibrillation; computational modeling; electrocardiographic mapping; fibrotic remodeling; reentrant drivers.

PubMed Disclaimer

Figures

Graphical Abstract
Graphical Abstract
This study presents a comparison between reentrant driver (RD)-harboring regions identified by electrocardiographic imaging (ECGI), conducted prior to catheter ablation in persistent atrial fibrillation (PsAF) patients, and via simulations conducted in patient-specific computational models reconstructed from late gadolinium-enhanced magnetic resonance imaging (LGE-MRI) scans. The finding of atrial regions in which both ECGI and simulations detected RDs (purple) suggests that PsAF is at least partially driven by fibrosis-mediated mechanisms. Simulations also identify “latent” RDs (red)—regions within the fibrotic substrate where an RD could persist, but never manifested during clinical mapping. Conversely, RD-harboring regions identified by ECGI but not in simulations (blue) indicate that some clinically mapped AF episodes were perpetuated by mechanisms other than the fibrotic substrate. Our retrospective analysis suggests that substrate-based ablation combining simulations with ECGI could improve outcomes.
Figure 1
Figure 1
Workflow for comparison of RDsim and RDECGI locations. Torso electrodes recorded 15 s of pre-ablation AF in PsAF patients (A), and unipolar electrograms were reconstructed (B). Phase maps (C) were analyzed to construct RD-phase singularity histograms (D). Each patient underwent LGE-MRI (E), which was used to reconstruct 3D atrial models (F). Programmed electrical stimulation induced in-silico AF (G), and fibrosis-driven RD-phase singularity trajectories in simulations were determined (H). RDs from ECGI and simulations were compared. Panel (A) is reused with permission from Cochet et al. (2018).
Figure 2
Figure 2
Schematic defining region classification. RDECGI and RDsim were classified into atrial regions as follows: (1/2) left/right PVs; (3) posterior LA; (4/5) superior/inferior RA; (6) anterior LA; and (7) inter-atrial groove. RDECGI- and RDsim-harboring regions in this schematic are for illustrative purposes only and are not related to any particular patient/model.
Figure 3
Figure 3
Summary of RD-related findings for all patients and corresponding models. Table shows fibrosis burden, number and distribution of RDsim- and RDECGI-harboring atrial regions, and acute clinical outcome of ECGI-driven ablation, i.e., continued AF or termination to sinus rhythm (SR) or atrial tachycardia (AT). Cell pairs are color-coded using the same scheme as Figure 2.
Figure 4
Figure 4
Relationship between the numbers of RDsim-harboring regions predicted by each model and RDECGI-harboring regions observed during clinically mapped AF in the corresponding patients. Solid and dotted lines indicate best fit for linear regression and 95% confidence intervals, respectively.
Figure 5
Figure 5
Spatial co-localization of RDsim (left) and RDECGI (right). (A) (patient 7): Matching RDsim and RDECGI sites in the left PV region. (B) (patient 3): Matching RDsim and RDECGI sites in the inter-atrial groove region.
Figure 6
Figure 6
Inter-rater agreement between RDsim and RDECGI regions in patient-derived models. Cells color-coded via same classification scheme used in Figure 3.
Figure 7
Figure 7
ECGI+/Sim+, ECGI+/Sim−, ECGI−/Sim+, and ECGI−/Sim− region examples. RD trajectories in regions of interest for each panel are highlighted by dashed yellow circles. (A) (patient 1): matching RD sites in both left PV and posterior LA regions. (B) (patient 2): RDECGI site in posterior LA region was not observed during simulations. (C) (patient 4): RDsim sites in inferior RA and inter-atrial groove were not observed during clinical mapping via ECGI. (D) (patient 11): Superior RA and anterior LA regions were free of RD activity in both simulations and ECGI. See Figure 5 for legend.
Figure 8
Figure 8
Regional distribution of ECGI+/Sim+, ECGI+/Sim-, ECGI-/Sim+ and ECGI-/Sim- regions. Each percentage value in each atrial region represents the proportion of all examples of the corresponding region classification (ECGI+/Sim+, etc.) corresponded to that region.
Figure 9
Figure 9
Outcome of RDECGI ablation in regions with and without RDsim. (A,B) Rates of AF termination and positive response to ablation in ECGI+/Sim− vs. ECGI+/Sim+ regions. (C) AF cycle length prolongation (median + upper/lower quartile lines) in response to ablation of RDECGI targets in ECGI+/Sim+ vs. ECGI+/Sim− regions.
Figure 10
Figure 10
Number of RDsim-harboring regions in five patient-derived models before and after ablation of RDsim targets. The first round of simulated ablation targeted sites within ECGI+/Sim+ regions only; the second additionally targeted RDs in ECGI−/Sim+ regions.

References

    1. Andrade J., Khairy P., Dobrev D., Nattel S. (2014). The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ. Res. 114, 1453–1468. 10.1161/CIRCRESAHA.114.303211 - DOI - PubMed
    1. Arora R., Verheule S., Scott L., Navarrete A., Katari V., Wilson E., et al. . (2003). Arrhythmogenic substrate of the pulmonary veins assessed by high-resolution optical mapping. Circulation 107, 1816–1821. 10.1161/01.CIR.0000058461.86339.7E - DOI - PMC - PubMed
    1. Boyle P. M., Zahid S., Trayanova N. A. (2016). Towards personalized computational modelling of the fibrotic substrate for atrial arrhythmia. Europace 18(suppl 4), iv136-iv145. 10.1093/europace/euw358 - DOI - PMC - PubMed
    1. Burstein B., Nattel S. (2008). Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J. Am. Coll. Cardiol. 51, 802–809. 10.1016/j.jacc.2007.09.064 - DOI - PubMed
    1. Calkins H., Hindricks G., Cappato R., Kim Y. H., Saad E. B., Aguinaga L., et al. . (2017). 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 14, e275–e444. 10.1016/j.hrthm.2017.05.012 - DOI - PMC - PubMed

LinkOut - more resources